Tadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boy...
FDA Drug Recall #D-0242-2019 — Class III — September 25, 2018
Recall Summary
| Recall Number | D-0242-2019 |
| Classification | Class III — Low risk |
| Date Initiated | September 25, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Right Value Drug Stores, Inc. |
| Location | Hurst, TX |
| Product Type | Drugs |
| Quantity | 660 capsules |
Product Description
Tadalafil SR 7 mg Capsules packed in 8,13, 20, 30, 40 or 60 dram screw top pill bottle, Carie Boyd's Prescription Shop 122 Grapevine Hwy. Hurst, TX 76054. NDC 99999-9970-88
Reason for Recall
Labeling Not Elsewhere Classified: Misbranding.
Distribution Pattern
Distributed in California
Lot / Code Information
Lots: 04242018@16 Exp. 10/21/2018; 05042018@17 Exp. 10/31/2018; 07232018@13 Exp. 01/19/2019; 08032018@2 Exp. 01/30/2019
Other Recalls from Right Value Drug Stores, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0243-2019 | Class III | Tadalafil SR 12 mg Capsules packed in 8,13, 20,... | Sep 25, 2018 |
| D-0241-2019 | Class III | Progesterone SR 200 mg Capsules, packed in 8,13... | Sep 25, 2018 |
| D-0240-2019 | Class III | Progesterone SR 100 mg Capsules, packed in 8,13... | Sep 25, 2018 |
| D-1047-2018 | Class III | Testosterone 200 mg Pellet, Rx only, Carie Boyd... | Jul 26, 2018 |
| D-0335-2015 | Class II | Glutathione 200 mg/mL Injectable, packaged in a... | Dec 12, 2014 |
Frequently Asked Questions
Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.